BackBristol-Myers Squibb Overview
Bristol-Myers Squibb Co.

Bristol-Myers Squibb P/E Ratio

Latest P/E ratio for Bristol-Myers Squibb: 14.67 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

14.67

P/E Ratio

14.67

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Bristol-Myers Squibb (BMY) FAQ

Bristol-Myers Squibb (BMY) currently reports a P/E ratio of 14.67. That is below the Healthcare sector average of 25.9. Use the charts on this page to explore Bristol-Myers Squibb's P/E ratio history and peer comparisons.

Bristol-Myers Squibb's P/E ratio of 14.67 is lower than the Healthcare sector average of 25.9. That is roughly 43.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Bristol-Myers Squibb's market price to a fundamental measure such as earnings, sales, or book value. At 14.67, BMY can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 14.67, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.9. From there, open related valuation or income-statement pages for Bristol-Myers Squibb, and consider following BMY for alerts when major investors trade the stock.

Bristol-Myers Squibb is classified in the Healthcare sector. On P/E ratio, it currently shows 14.67 versus a sector average near 25.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BMY with unrelated industries.